Reliability and Validity of the Korean Version of the Somatic Symptom Disorder-B Criteria Scale in a Clinical Population.

IF 1.8 4区医学 Q3 PSYCHIATRY Psychiatry Investigation Pub Date : 2024-02-01 Epub Date: 2024-02-22 DOI:10.30773/pi.2023.0352

Saim Jung, Joon Sung Shin, Sun Hyung Lee, Sungwon Lee, Jaehyun Kim, Kyung-Lak Son, Bong-Jin Hahm, Chan-Woo Yeom

{"title":"Reliability and Validity of the Korean Version of the Somatic Symptom Disorder-B Criteria Scale in a Clinical Population.","authors":"Saim Jung, Joon Sung Shin, Sun Hyung Lee, Sungwon Lee, Jaehyun Kim, Kyung-Lak Son, Bong-Jin Hahm, Chan-Woo Yeom","doi":"10.30773/pi.2023.0352","DOIUrl":null,"url":null,"abstract":"Objective: This study aimed to develop and validate the Korean version of the Somatic Symptom Disorder-B Criteria Scale (SSD-12) in outpatients at a psychiatric clinic and assess its diagnostic accuracy.Methods: A total of 207 patients completed SSD-12. For the diagnostic accuracy of SSD-12, the somatic symptom disorder (SSD) section of the structured clinical interview for DSM-5 disorders-research version (SCID-5-RV) was used. The SSD-12 construct and concurrent validity were assessed by examining the correlations with Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-9 (PHQ-9), PHQ-15, 5-level EQ-5D version (EQ-5D-5L), and World Health Organization Quality of Life Brief Version (WHOQOL-BREF).Results: The SSD-12 had excellent internal consistency (Cronbach α=0.90). Confirmatory factor analysis revealed good fit indices for a general factor model (comparative fit index [CFI]=0.92, Tucker-Lewis index [TLI]=0.88, root mean square error of approximation [RMSEA]=0.10; 95% confidence interval [CI], 0.08-0.11) and a three-factor model (CFI=0.94, TLI=0.91, RMSEA=0.08; 95% CI, 0.07-0.10). The total SSD-12 score was significantly correlated with anxiety (GAD-7: r=0.53, p<0.001), depression (PHQ-9: r=0.52, p<0.001), physical symptom burden (PHQ-15: r=0.36, p<0.001), and quality of life (EQ-5D-5L: r=-0.40, p<0.001; WHOQOL-BREF: r=-0.51, p<0.001). SSD-12 demonstrated good accuracy (area under the curve=0.75, standard error=0.04; 95% CI, 0.68-0.82) with an optimal cut-off of 29.Conclusion: The Korean SSD-12 demonstrates reliability and validity for diagnosing SSD in clinical setting.","PeriodicalId":21164,"journal":{"name":"Psychiatry Investigation","volume":"21 2","pages":"165-173"},"PeriodicalIF":1.8000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10910159/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychiatry Investigation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.30773/pi.2023.0352","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/22 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PSYCHIATRY","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: This study aimed to develop and validate the Korean version of the Somatic Symptom Disorder-B Criteria Scale (SSD-12) in outpatients at a psychiatric clinic and assess its diagnostic accuracy.

Methods: A total of 207 patients completed SSD-12. For the diagnostic accuracy of SSD-12, the somatic symptom disorder (SSD) section of the structured clinical interview for DSM-5 disorders-research version (SCID-5-RV) was used. The SSD-12 construct and concurrent validity were assessed by examining the correlations with Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-9 (PHQ-9), PHQ-15, 5-level EQ-5D version (EQ-5D-5L), and World Health Organization Quality of Life Brief Version (WHOQOL-BREF).

Results: The SSD-12 had excellent internal consistency (Cronbach α=0.90). Confirmatory factor analysis revealed good fit indices for a general factor model (comparative fit index [CFI]=0.92, Tucker-Lewis index [TLI]=0.88, root mean square error of approximation [RMSEA]=0.10; 95% confidence interval [CI], 0.08-0.11) and a three-factor model (CFI=0.94, TLI=0.91, RMSEA=0.08; 95% CI, 0.07-0.10). The total SSD-12 score was significantly correlated with anxiety (GAD-7: r=0.53, p<0.001), depression (PHQ-9: r=0.52, p<0.001), physical symptom burden (PHQ-15: r=0.36, p<0.001), and quality of life (EQ-5D-5L: r=-0.40, p<0.001; WHOQOL-BREF: r=-0.51, p<0.001). SSD-12 demonstrated good accuracy (area under the curve=0.75, standard error=0.04; 95% CI, 0.68-0.82) with an optimal cut-off of 29.

Conclusion: The Korean SSD-12 demonstrates reliability and validity for diagnosing SSD in clinical setting.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

韩国版躯体症状障碍-B 标准量表在临床人群中的可靠性和有效性。

研究目的本研究的目的是在一家精神科诊所的门诊患者中开发并验证韩国版躯体症状障碍-B标准量表（SSD-12），并评估其诊断准确性：共有 207 名患者填写了 SSD-12。方法：共有 207 名患者填写了 SSD-12，并使用了 DSM-5 疾病结构化临床访谈研究版（SCID-5-RV）中的躯体症状障碍（SSD）部分来评估 SSD-12 的诊断准确性。通过研究SSD-12与广泛性焦虑症-7（GAD-7）、患者健康问卷-9（PHQ-9）、PHQ-15、5级EQ-5D版本（EQ-5D-5L）和世界卫生组织生活质量简明版（WHOQOL-BREF）的相关性，评估了SSD-12的构建有效性和并发有效性：SSD-12具有良好的内部一致性（Cronbach α=0.90）。确认性因素分析显示，一般因素模型（比较拟合指数[CFI]=0.92，塔克-刘易斯指数[TLI]=0.88，均方根近似误差[RMSEA]=0.10；95%置信区间[CI]，0.08-0.11）和三因素模型（CFI=0.94，TLI=0.91，RMSEA=0.08；95%置信区间，0.07-0.10）的拟合指数良好。SSD-12 总分与焦虑（GAD-7：r=0.53，p 结论：韩国SSD-12在临床诊断SSD方面具有可靠性和有效性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Psychiatry Investigation PSYCHIATRY-

CiteScore

4.10

自引率

3.70%

发文量

105

审稿时长

6-12 weeks

期刊介绍： The Psychiatry Investigation is published on the 25th day of every month in English by the Korean Neuropsychiatric Association (KNPA). The Journal covers the whole range of psychiatry and neuroscience. Both basic and clinical contributions are encouraged from all disciplines and research areas relevant to the pathophysiology and management of neuropsychiatric disorders and symptoms, as well as researches related to cross cultural psychiatry and ethnic issues in psychiatry. The Journal publishes editorials, review articles, original articles, brief reports, viewpoints and correspondences. All research articles are peer reviewed. Contributions are accepted for publication on the condition that their substance has not been published or submitted for publication elsewhere. Authors submitting papers to the Journal (serially or otherwise) with a common theme or using data derived from the same sample (or a subset thereof) must send details of all relevant previous publications and simultaneous submissions. The Journal is not responsible for statements made by contributors. Material in the Journal does not necessarily reflect the views of the Editor or of the KNPA. Manuscripts accepted for publication are copy-edited to improve readability and to ensure conformity with house style.